US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sanofi

96.86

+2.702.87%

Post-market: 93.59-3.2656-3.37%17:17 EST

Volume:136.20K

Turnover:12.75M

Market Cap:118.12B

PE:17.77

High:96.86

Open:93.75

Low:93.75

Close:94.16

52wk High:122.03

52wk Low:90.05

Shares:1.22B

Float Shares:1.10B

Volume Ratio:1.88

T/O Rate:0.01%

Dividend:4.51

Dividend Rate:4.66%

EPS(TTM):5.45

EPS(LYR):4.60

ROE:6.66%

ROA:4.56%

PB:1.40

PE(LYR):21.06

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Sanofi Wins Positive EU CHMP Opinion for Rezurock in Chronic Graft-Versus-Host Disease

Kepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)

Sanofi's Rezurock Expands Provincial Access in Canada

MT Newswires Live

Sanofi Launches $1.18 Billion Share Buyback Program

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SNYNF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNYNF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNYNF\",,,,,undefined,":{"symbol":"SNYNF","market":"US","secType":"STK","nameCN":"Sanofi","latestPrice":96.86,"timestamp":1770411600000,"preClose":94.1619,"halted":0,"volume":136195,"hourTrading":{"tag":"盘后","latestPrice":93.5944,"preClose":96.86,"latestTime":"17:17 EST","volume":135000,"amount":12633543,"timestamp":1770416249362,"change":-3.2656,"changeRate":-0.033715,"amplitude":0.00026},"delay":15,"changeRate":0.028653839822688335,"floatShares":1098441430,"shares":1219473844,"eps":5.452053,"marketStatus":"Market Closed","change":2.6981,"latestTime":"02-06 17:17:29 EST Delay","open":93.75,"high":96.86,"low":93.75,"amount":12747902.1571,"amplitude":0.033028,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":5.452053,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":94.1619,"volumeRatio":1.8785828176633843},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNYNF\",,,,,undefined,":{"symbol":"SNYNF","floatShares":1098441430,"roa":"4.56%","roe":"6.66%","lyrEps":4.599879,"volumeRatio":1.8785828176633843,"shares":1219473844,"dividePrice":4.510199,"high":96.86,"amplitude":0.033028,"preClose":94.1619,"low":93.75,"week52Low":90.05,"pbRate":"1.40","psRate":"2.14","week52High":122.028,"institutionHeld":0,"latestPrice":96.86,"eps":5.452053,"divideRate":0.046564,"volume":136195,"delay":15,"ttmEps":5.452053,"open":93.75,"prevYearClose":97.295,"prevWeekClose":91.11,"prevMonthClose":91.11,"prevQuarterClose":97.295,"fiveDayClose":91.11,"twentyDayClose":96.23,"sixtyDayClose":100.575},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNYNF\",params:#limit:5,,,undefined,":[{"date":"2025-05-12","symbol":"SNYNF","amount":3.92,"announcedDate":"2025-01-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-13","defaultRemindTime":1747056600000,"name":"Sanofi","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-14","payableDate":"2025-05-13","currency":"EUR","dateTimestamp":1747022400000,"payDate":"2025-05-14"},{"date":"2024-05-13","symbol":"SNYNF","amount":3.76,"announcedDate":"2024-02-01","type":"dividend","market":"US","newRecordDate":"2024-05-14","defaultRemindTime":1715607000000,"name":"Sanofi","recordDate":"2024-05-15","payableDate":"2024-05-14","currency":"EUR","dateTimestamp":1715572800000,"payDate":"2024-05-15"},{"market":"US","date":"2024-04-25","symbol":"SNYNF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"pre","actualEps":null},{"date":"2023-05-30","symbol":"SNYNF","amount":3.56,"announcedDate":"2023-02-03","type":"dividend","market":"US","newRecordDate":"2023-05-31","defaultRemindTime":1685453400000,"name":"Sanofi","recordDate":"2023-06-01","payableDate":"2023-05-31","currency":"EUR","dateTimestamp":1685419200000,"payDate":"2023-06-01"},{"date":"2022-10-28","symbol":"SNYNF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1666944000000,"name":null,"time":"Pre-Market","dateTimestamp":1666929600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNYNF\",market:\"US\",,,undefined,":[{"executeDate":"2019-05-09","recordDate":"2019-05-10","paymentDate":"2019-05-13","value":3.07,"currency":"EUR"},{"executeDate":"2020-05-04","recordDate":"2020-05-05","paymentDate":"2020-05-06","value":3.15,"currency":"EUR"},{"executeDate":"2021-05-05","recordDate":"2021-05-06","paymentDate":"2021-05-07","value":3.2,"currency":"EUR"},{"executeDate":"2022-05-06","recordDate":"2022-05-09","paymentDate":"2022-05-10","value":3.33,"currency":"EUR"},{"executeDate":"2023-05-30","recordDate":"2023-05-31","paymentDate":"2023-06-01","value":3.56,"currency":"EUR"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNYNF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNYNF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609597957","title":"Sanofi Wins Positive EU CHMP Opinion for Rezurock in Chronic Graft-Versus-Host Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2609597957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609597957?lang=en_us&edition=fundamental","pubTime":"2026-02-06 23:29","pubTimestamp":1770391748,"startTime":"0","endTime":"0","summary":"Sanofi ( ($SNY) ) has shared an announcement. On January 30, 2026, Sanofi announced that the European Medicines Agency’s Committee for Medicinal Pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sanofi-wins-positive-eu-chmp-opinion-for-rezurock-in-chronic-graft-versus-host-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sanofi-wins-positive-eu-chmp-opinion-for-rezurock-in-chronic-graft-versus-host-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNYNF","BK4087","CHMP","BK4156","BK4181","BK4585","BK4007","HST","BK4588","BK4218"],"gpt_icon":0},{"id":"2609452243","title":"Kepler Capital  Sticks to Its Hold Rating for Sanofi (SNYNF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609452243","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609452243?lang=en_us&edition=fundamental","pubTime":"2026-02-05 10:15","pubTimestamp":1770257727,"startTime":"0","endTime":"0","summary":"In a report released on February 3, Nicolas Pauillac from Kepler Capital maintained a Hold rating on Sanofi, with a price target of €85.00. The com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-sticks-to-its-hold-rating-for-sanofi-snynf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-sticks-to-its-hold-rating-for-sanofi-snynf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNYNF"],"gpt_icon":0},{"id":"2608804751","title":"Sanofi's Rezurock Expands Provincial Access in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2608804751","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608804751?lang=en_us&edition=fundamental","pubTime":"2026-02-04 03:04","pubTimestamp":1770145482,"startTime":"0","endTime":"0","summary":"Sanofi  said Tuesday that Rezurock, or belumosudil, has been added to the provincial formularies in Canada's British Columbia and Ontario for adult and pediatric patients aged 12 and older with chronic graft-versus-host disease, or GVHD, who have not responded to at least two prior systemic therapies.This follows Rezurock's coverage in Quebec since November 2025, the company said, adding that full reimbursement criteria are available on provincial and Canada Drug Agency websites.Chronic GVHD is a serious complication that can occur after a stem cell transplant, when donor cells attack the patient's body, the company said.Price: 47.46, Change: +0.19, Percent Change: +0.40","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SNYNF","IE00BFXG1179.USD","SNY","BK4585","BK4588","BK4007"],"gpt_icon":0},{"id":"2608582687","title":"Sanofi Launches $1.18 Billion Share Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2608582687","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608582687?lang=en_us&edition=fundamental","pubTime":"2026-02-03 16:48","pubTimestamp":1770108495,"startTime":"0","endTime":"0","summary":"Sanofi (SNY) said Tuesday it plans to implement a 1 billion euro ($1.18 billion) share buyback program in 2026.The program is valid from Feb. 3 to Dec. 31, the drugmaker said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SNYNF","BK4585","IE00BFXG1179.USD","BK4007","BK4588","SNY"],"gpt_icon":0}],"pageSize":4,"totalPage":42,"pageCount":1,"totalSize":168,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SNYNF\",params:#limit:6,delay:false,,,undefined,":[]}}